MindMaze Therapeutics Holding SA (RLFTF) Financials
All currency values in CHF millions unless otherwise noted
Scroll
| Income Statement | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 | DEC 2020 |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | CHF 8 | CHF 6 | CHF 6 | CHF 3 | CHF 0 |
| Cost of Revenue | CHF 3 | CHF 2 | CHF 1 | CHF 20 | CHF 14 |
| Gross Profit | CHF 6 | CHF 4 | CHF 5 | -CHF 16 | -CHF 14 |
| Total Operating Expenses | CHF 14 | CHF 24 | CHF 40 | CHF 18 | CHF 7 |
| Operating Income | -CHF 8 | -CHF 20 | -CHF 35 | -CHF 35 | -CHF 20 |
| Non-Operating | |||||
| Net Interest Expense | -CHF 0 | -CHF 0 | -CHF 1 | -CHF 1 | -CHF 0 |
| Income Tax Expense | -CHF 2 | -CHF 14 | -CHF 4 | -CHF 1 | CHF 2 |
| Net Income | |||||
| Net Income | -CHF 17 | -CHF 98 | -CHF 51 | -CHF 35 | -CHF 8 |
| Per Share Data | |||||
| Revenue Per Share | CHF 0.67 | CHF 0.51 | CHF 0.58 | CHF 0.45 | CHF 0.00 |
| EPS (Basic) | -CHF 1.37 | -CHF 8.35 | -CHF 4.81 | -CHF 4.00 | -CHF 1.20 |
| EPS (Diluted) | -CHF 1.37 | -CHF 8.35 | -CHF 4.81 | -CHF 4.00 | -CHF 1.20 |
| Shares Outstanding | 12.5M | 11.8M | 10.6M | 7.3M | 4.9M |
MindMaze Therapeutics Holding SA (RLFTF) financials: revenue, profit and margins
MindMaze Therapeutics Holding SA (RLFTF) generated about CHF 8 million in revenue and -CHF 17 million in net income (a -203.4% net margin) over the trailing twelve months, growing at roughly 36.3% a year. Figures are from company filings; this is analysis, not investment advice.
Frequently asked
What is MindMaze Therapeutics Holding SA's (RLFTF) revenue?+
MindMaze Therapeutics Holding SA generated about CHF 8 million in revenue over the trailing twelve months. Revenue has grown at roughly 36.3% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is MindMaze Therapeutics Holding SA profitable?+
MindMaze Therapeutics Holding SA reported about -CHF 17 million in net loss over the trailing twelve months, a net margin of roughly -203.4%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are MindMaze Therapeutics Holding SA's profit margins?+
MindMaze Therapeutics Holding SA runs a gross margin of about 69.4%, an operating margin of about -93.9%, a net margin of about -203.4%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is MindMaze Therapeutics Holding SA growing?+
MindMaze Therapeutics Holding SA's revenue has compounded at roughly 36.3% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside RLFTF's margins and free cash flow. This is analysis from company filings, not investment advice.
Related stocks: Biotechnology
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.